This document answers the next-level evaluator question: not “has the founder thought about the case?” but “can the thinking be connected to raw evidence, verification methods, independent reviewers, and deal-ready diligence?”
Core position: the Linas 12-skill package is an evaluation and argument map, not the final diligence room. Its purpose is to define what must be verified, what artifacts should be reviewed, what disclosure level applies, and which independent reviewer should test each material claim.
A strong argument is not enough. The next stage is claim-level auditability.
The statement being made: users, asset count, solo creation, MVP, patent-grade claim, buyer path, valuation logic.
Where the evaluator should go first: public page, restricted file, evidence table, source record, or NDA-only package.
The underlying material: export, screenshot, database, invoice, timestamp, file metadata, contract, analytics, source document.
The method: audit, metadata check, product review, analytics validation, financial review, prior-art search, benchmark, interview.
| Claim Type | Current Public Status | Raw Artifact Type | Verification Method | Reviewer | Disclosure Level |
|---|---|---|---|---|---|
| Phase 1 MVP existed | Publicly described; summary available. | Screenshots, demos, app flows, module docs, code/product evidence. | Product walkthrough and artifact review. | Product / technical reviewer. | Restricted review |
| Phase 1 users / sellers / transactions | Publicly referenced; raw proof should be audited. | Analytics, database exports, seller records, transaction logs, invoices. | Analytics and operations audit. | Data/product analyst. | NDA likely |
| ~$700K personal capital deployment | Publicly referenced; financial review required. | Transfers, invoices, contracts, payroll/expense ledgers, bank trails. | Financial reconstruction and sampling. | Accountant / financial reviewer. | NDA |
| Phase 2 solo formation | Central claim; must be reconstructed. | Timestamps, file history, drafts, subscriptions, session artifacts, metadata, absence of contractor/team records. | Provenance audit and timeline reconstruction. | Independent evaluator / forensic reviewer. | NDA |
| 330+ asset portfolio | Mapped in public summary; index required. | Asset inventory, file repository, metadata, maturity labels, source hierarchy. | Completeness and maturity review. | Technical/commercial evaluator. | Restricted review |
| 22+ patent-grade claims | Patent-grade candidates, not granted patents. | Claim table, specs, diagrams, dated files, disclosure status. | Prior-art search, patentability analysis, claim refinement. | IP counsel / patent strategist. | NDA |
| Legal/governance readiness | Mapped; not complete. | Risk register, disclosure map, phase boundaries, NDA logic, legal-access context. | Legal and governance review. | Counsel / compliance expert. | Restricted review |
The correct answer should be precise, not defensive.
At the current public layer, it is primarily an argument and evaluation map. It is not presented as the final independent diligence room. That is intentional: the public layer should orient reviewers without forcing exposure of sensitive, patent-relevant, security-sensitive, financial, or personal data.
The purpose of the 12-skill package is to define the diligence-room architecture: which claims matter, what evidence should support them, what disclosure level applies, and what type of independent reviewer should test each claim.
The next step is to attach each material claim to the chain: Claim → Evidence link → Raw artifact → Verification method → Independent reviewer.
Phase 1 is used as execution and market-response evidence, not as the Phase 2 solo claim or valuation base.
It should be. Phase 1 should be reviewed through raw MVP evidence, screenshots, product flows, user/seller records, analytics exports, transaction records, invoices, business documents, team records, and operational files.
The 12-skill files do not ask evaluators to accept Phase 1 on narrative alone. They identify Phase 1 as an evidence category requiring product, analytics, financial, and operations review.
Validation should use sampled raw artifacts: database exports, Google Analytics or equivalent analytics views, seller/business records, transaction logs, campaign records, screenshots, product-page counts, invoices, and operational communications.
A reviewer should be able to test whether the numbers are consistent across independent records rather than only repeated in narrative form.
It should be tested through transfer records, invoices, contractor/team payments, contracts, payroll or expense ledgers, bank records where available, and a reconstructed expense timeline.
This does not need to be public. It belongs in the financial diligence layer, likely under NDA.
The team should be classified clearly: employees, contractors, developers, freelancers, vendors, interns, partners, or other roles. Their role should be mapped to Phase 1 only.
This matters because Phase 1 proves execution and team operations, while Phase 2 is the solo asset-formation claim.
Yes, but carefully. Phase 1 market learning informs Phase 2 architecture and asset formation, especially Mazzaneh, Radar/Begir, Board, Pulino, Analytics, commerce loops, seller logic, and productization paths.
But Phase 1 implementation is not counted as solo Phase 2 output and should not be used as the valuation base for the broader Phase 2 portfolio.
The burden is not only “I was solo.” The burden is whether the formation path can be audited.
The diligence room should define a precise Phase 2 start date, end date, and sub-periods: asset formation, documentation, website/public layer, evaluator files, and Phase 3 preparation.
Any ambiguity should be resolved through timestamps, file histories, publication dates, subscription records, and source hierarchy.
Through a provenance package: dated files, drafts, metadata, prompt/session exports where available, AI subscription/payment records, version histories, publication timelines, artifact evolution, and evidence that no human cofounder, hidden team, agency, contractor stack, advisor group, API stack, or agent workforce formed the Phase 2 asset stack.
The test is practical: can the work’s formation path be reconstructed well enough for an independent reviewer to see who did what, when, and with which tools?
The Phase 3 diligence room should include an asset creation index: asset name, category, first date, latest version, tool/process used, maturity level, evidence file, public/restricted status, and next validation step.
The public claim should not stand alone. The index is the bridge between portfolio narrative and auditable evidence.
Yes, where available. Useful artifacts include account/subscription records, downloaded chats or session exports, generated drafts, document metadata, local file timestamps, version histories, publication timestamps, and cross-model comparison files.
Not every session must be public or available, but enough provenance should exist to support the formation pattern.
They should be documented as part of the methodology record: which tools were used, what role they played, and where the founder’s judgment entered as selection, rejection, synthesis, integration, and system memory.
The claim is not “AI was absent.” The claim is “no human team or agent/API workforce formed the portfolio.”
A one-person AI-native case is credible only if the formation path is auditable. The story must become a timeline; the timeline must connect to artifacts; the artifacts must survive independent review.
The evaluator should not ask whether all 330+ assets are complete products. The evaluator should ask how each asset is classified.
| Maturity Level | Definition | Evidence Needed | Reviewer |
|---|---|---|---|
| Concept | Idea or direction with strategic logic but no product spec yet. | Dated note, concept doc, problem framing. | Strategy reviewer. |
| Documented spec | Structured product/technical specification. | Spec file, architecture, flows, constraints. | Product / technical reviewer. |
| Prototype | Interactive or functional demonstration. | Demo video, screenshots, repo/files, test notes. | Product / engineering reviewer. |
| MVP / tested | Used in real or semi-real market/product context. | User records, analytics, transactions, pilot evidence. | Product/data reviewer. |
| Rebuild-ready | Prior MVP or architecture ready for modern Phase 3 rebuild. | Requirements, MVP proof, rebuild roadmap, buyer/user logic. | Product lead / partner. |
| Patent-ready candidate | Claim appears patent-grade but needs counsel review. | Claim table, diagrams, novelty hypothesis, disclosure status. | IP counsel. |
| Commercialization-ready candidate | Has buyer, problem, path, and proof requirement. | Buyer map, pilot plan, pricing logic, proof package. | Commercial evaluator. |
| Research-track | Foundational theory or research direction. | Research brief, conceptual map, critique path. | Scientific/research reviewer. |
| NDA-only / reserved | Sensitive technical, security, patent, or partner material. | Controlled package, access log, reviewer qualification. | Qualified expert under NDA. |
The answer should remain context-dependent until partner fit is known. Mazzaneh AI-commerce is the clearest product-first entry for public startup applications because it has Phase 1 MVP evidence. GPU Sentinel may be stronger for enterprise/cloud/security buyers. HUAI may be faster for advisory or enterprise AI assessment. Tokenizer or LLM Optimization may fit AI-lab or infrastructure review.
The correct first entry should be chosen by counterparty, evidence strength, time-to-validation, and risk.
Each asset should have a mini-diligence card: buyer, problem, evidence, maturity, deployment path, validation method, disclosure level, and next step.
This distinction protects the case from overclaiming and makes Phase 3 legal work clearer.
They should be presented as a claim table: title, asset, problem, proposed novelty, evidence file, first date, public disclosure status, likely IP route, prior-art status, and next counsel action.
The public layer should not imply that these are granted patents. They are patent-grade or patent-candidate directions pending professional review.
The cautious position is: founder-level patentability hypotheses exist, but formal prior-art search, novelty analysis, claim drafting, jurisdiction strategy, and filing decisions belong to Phase 3 IP counsel.
This must be decided asset-by-asset. Some claims may fit utility patents; some may be better as trade secrets; some are copyright/spec/IP packages; some are research-track and should be exposed through controlled expert critique or publication strategy.
Potentially, depending on jurisdiction, timing, and disclosure detail. That is why MZN separates public, restricted, confidential, and reserved layers.
Phase 3 counsel should review which public pages reveal enough to affect patent strategy and which materials should remain NDA-only.
Public pages orient evaluators. Restricted files support evidence review. Confidential materials support partner/deal review. Reserved materials include security-sensitive, patent-sensitive, research-sensitive, or misuse-prone details that require qualified reviewers.
Buyer logic must be asset-specific.
| Asset / Layer | Likely First Buyer / Partner | Why They Pay | Revenue / Deal Path | Evidence Needed |
|---|---|---|---|---|
| Mazzaneh / Board / Pulino / Analytics | Commerce partner, regional operator, retail ecosystem, ads/rewards partner. | Demand capture, verified engagement, seller/customer loops, rewarded commerce. | JV, rebuild, SaaS/adtech, platform partnership. | MVP proof, market data, rebuild plan, compliance review. |
| GPU Sentinel | GPU cloud provider, enterprise security buyer, infrastructure operator. | GPU risk visibility, abuse detection, FinOps, audit posture. | Enterprise pilot, license, strategic partnership. | Telemetry benchmark, 90-day pilot, security review. |
| Tokenizer / LLM Optimization | AI lab, model provider, inference infrastructure company. | Cost, compression, multilingual stability, safety boundaries, routing improvement. | Benchmark pilot, technical license, lab partnership. | Comparative benchmarks, integration tests, IP review. |
| HUAI / ZOE | Enterprise AI teams, consulting firms, AI strategy groups. | Capability mapping, LLM company anatomy, build-vs-buy decisions. | Framework license, advisory, enterprise assessment. | Sample assessment, methodology review, buyer-specific adaptation. |
| BioCode | Research institution, biotech-AI lab, advanced research group. | Foundational research option and conceptual architecture. | Sponsored research, research partnership, option collaboration. | Expert critique, scientific review, controlled disclosure. |
| Zoyan | Wearable AI company, consumer AI platform, device partner. | Personal AI interface, intent, memory, privacy-sensitive user layer. | Co-development, app/device pilot, strategic option. | UX prototype, privacy review, hardware/software feasibility. |
The likely first payer depends on the selected Phase 3 entry asset. A TechCrunch-style public startup path likely begins with Mazzaneh AI-commerce. A technical enterprise path may begin with GPU Sentinel. A fast advisory path may begin with HUAI.
Buyer interviews, LOIs, pilot interest, introductions, or partner emails should be collected in a commercial diligence folder.
It must be. Strategic value can be portfolio-level, but revenue validation is asset-specific. A serious diligence room should show which assets have near-term buyer paths and which are long-term option value.
This is one of the most important guardrails.
What would it cost a traditional team to recreate the credible assets, documentation, technical paths, and evidence structure?
What is the value of multiple patent-grade candidates, trade secret options, and research/technical directions?
What would a strategic buyer pay for time, optionality, architecture, and asset synergy?
Which assets can license independently, and what proof is required before licensing?
Can commerce, rewards, analytics, AI interface, and infrastructure layers compound into a platform?
How much value comes from multiple entry paths rather than one product bet?
A serious valuation review should ask: what if only five assets validate? What if IP becomes trade-secret value rather than patents? What if Mazzaneh and GPU Sentinel validate but BioCode remains research-track? What if the first revenue path is advisory rather than SaaS?
The evaluator should not be forced into a binary of “worth $1B today” or “worth nothing.” The serious conclusion may be: not a certified billion-dollar company today, but a credible strategic-value candidate worthy of formal review.
The legal plan must be specific enough to guide Phase 3.
The first legal workstreams should be: company structure, IP assignment and ownership, patent counsel review, sanctions/compliance review, NDA/data-room setup, employment/contractor cleanup for Phase 1 records, investor/partner documentation, privacy/data governance, and deal-structure templates.
The main risks include overclaiming, IP/prior-art issues, unclear phase boundaries, insufficient raw evidence, security disclosure risk, privacy/data risk, valuation inflation, public inconsistency risk, and execution risk.
The correct mitigation is not to hide these risks, but to map them and assign each to a reviewer and workstream.
At minimum: NDA process, source hierarchy, evidence-room map, asset maturity matrix, claim table, disclosure map, Phase 1/Phase 2 boundary note, top evidence pack, and a clear explanation of what is public, restricted, confidential, and reserved.
Media, TechCrunch, Linas, investors, and technical reviewers need different entry points.
It can, if presented as a conclusion. It is safer and stronger when presented as a review question: “Can this one-person AI-native asset-formation case survive independent diligence?”
The public line should be: audited, not claimed.
They should be given a fixed path: core questions, phase boundary, top 10 evidence pack, asset maturity matrix, claim table, and legal-readiness plan.
Without that path, the case may feel too large. With that path, the evaluator can decide whether formal review is justified.
Yes. TechCrunch should focus on Mazzaneh/MZN AI-commerce as a product-first, previously tested MVP with a Phase 3 international path. The Linas/evaluator path should focus on the broader one-person asset-formation claim and evidence room.
If an evaluator has only 90 minutes, these are the materials that should determine whether the case is serious enough for formal independent review.
| # | Document / Evidence Pack | Purpose | Status Label | Reviewer |
|---|---|---|---|---|
| 1 | Phase 1 MVP proof | Show original Mazzaneh product existed and had real module implementation. | Restricted summary + artifacts | Product reviewer |
| 2 | Phase 1 user/seller/transaction evidence | Validate market response, sellers, businesses, users, analytics, and transaction records. | NDA / raw evidence | Data analyst |
| 3 | Phase 1 capital deployment proof | Test the ~$700K personal capital claim through financial records. | NDA financial review | Accountant / financial reviewer |
| 4 | Team / operation proof | Classify the 27-person Phase 1 execution team and operational roles. | NDA / role records | Operations reviewer |
| 5 | Phase 2 solo creation timeline | Reconstruct dates, tools, files, versions, and formation path. | NDA provenance package | Independent evaluator |
| 6 | 330+ asset index | List assets with categories, dates, maturity, evidence files, and disclosure level. | Restricted index | Technical/commercial reviewer |
| 7 | Top 20 asset maturity matrix | Separate productizable assets from concepts, research, specs, prototypes, and reserved material. | Restricted matrix | Product / strategy reviewer |
| 8 | 22+ patent-grade claim table | Show candidate claims, disclosure status, novelty hypothesis, and next counsel action. | NDA / IP review | IP counsel |
| 9 | Evidence hierarchy / data-room map | Explain which source controls, what is public/restricted/reserved, and where each claim is verified. | Core map | Lead evaluator |
| 10 | Phase 3 execution and legal-readiness plan | Show how the case moves from formation into legal, technical, commercial, and partner execution. | Review-ready | Legal/commercial evaluator |
The evaluator does not need to conclude “this is worth $1B” in 90 minutes. The evaluator needs to decide whether the evidence is serious enough to justify a formal independent review process.
The current package is strong as an evaluation map. It should not be treated as final proof. The correct next step is to convert the map into a diligence room where every material claim can be tested through raw artifacts, independent review, and appropriate disclosure controls.
The question is no longer “has the founder thought about this?” The question is: can the thinking be connected to an auditable evidence chain?
That is exactly the next phase.